- Home
- IBM vs ABT Comparison
IBM vs ABT Comparison
Compare IBM & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBM
- ABT
- Stock Information
- Founded
- IBM 1911
- ABT 1888
- Country
- IBM United States
- ABT United States
- Employees
- IBM N/A
- ABT N/A
- Industry
- IBM Computer Manufacturing
- ABT Medical/Dental Instruments
- Sector
- IBM Technology
- ABT Health Care
- Exchange
- IBM Nasdaq
- ABT Nasdaq
- Market Cap
- IBM 219.5B
- ABT 221.0B
- IPO Year
- IBM N/A
- ABT N/A
- Fundamental
- Price
- IBM $249.20
- ABT $133.23
- Analyst Decision
- IBM Buy
- ABT Buy
- Analyst Count
- IBM 14
- ABT 18
- Target Price
- IBM $254.21
- ABT $140.44
- AVG Volume (30 Days)
- IBM 4.8M
- ABT 6.9M
- Earning Date
- IBM 04-23-2025
- ABT 04-16-2025
- Dividend Yield
- IBM 2.70%
- ABT 1.77%
- EPS Growth
- IBM N/A
- ABT 139.92
- EPS
- IBM 5.83
- ABT 7.70
- Revenue
- IBM $62,832,000,000.00
- ABT $42,344,000,000.00
- Revenue This Year
- IBM $4.78
- ABT $7.45
- Revenue Next Year
- IBM $4.65
- ABT $7.70
- P/E Ratio
- IBM $42.78
- ABT $17.30
- Revenue Growth
- IBM 1.23
- ABT 5.00
- 52 Week Low
- IBM $163.53
- ABT $99.71
- 52 Week High
- IBM $266.45
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- IBM 55.54
- ABT 58.53
- Support Level
- IBM $234.34
- ABT $130.70
- Resistance Level
- IBM $256.52
- ABT $135.22
- Average True Range (ATR)
- IBM 5.39
- ABT 2.75
- MACD
- IBM 1.94
- ABT 0.44
- Stochastic Oscillator
- IBM 77.18
- ABT 63.08
About IBM International Business Machines Corporation
IBM looks to be a part of every aspect of an enterprise's IT needs. The company primarily sells software, IT services, consulting, and hardware. IBM operates in 175 countries and employs approximately 300,000 people. The company has a robust roster of business partners to service its clients, which include 95% of all Fortune 500 companies. Primary products include its mainframes, Red Hat software, transaction processing software, and IT consulting.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.